This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKimm-Breschkin, J. L.
Right arrow Articles by Varghese, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKimm-Breschkin, J. L.
Right arrow Articles by Varghese, J. N.

 Previous Article  |  Next Article 

J Virol, March 1998, p. 2456-2462, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Mutations in a Conserved Residue in the Influenza Virus Neuraminidase Active Site Decreases Sensitivity to Neu5Ac2en-Derived Inhibitors

Jennifer L. McKimm-Breschkin,1,* Anjali Sahasrabudhe,1 Tony J. Blick,1 Mandy McDonald,1 Peter M. Colman,1 Graham J. Hart,2 Richard C. Bethell,2 and Joseph N. Varghese1

Biomolecular Research Institute, Parkville, Australia,1 and Enzyme Pharmacology Unit, Glaxo Wellcome Research and Development Ltd., Stevenage SG1 2NY, United Kingdom2

Received 13 October 1997/Accepted 24 November 1997

The influenza virus neuraminidase (NA)-specific inhibitor zanamivir (4-guanidino-Neu5Ac2en) is effective in humans when administered topically within the respiratory tract. The search for compounds with altered pharmacological properties has led to the identification of a novel series of influenza virus NA inhibitors in which the triol group of zanamivir has been replaced by a hydrophobic group linked by a carboxamide at the 6 position (6-carboxamide). NWS/G70C variants generated in vitro, with decreased sensitivity to 6-carboxamide, contained hemagglutinin (HA) and/or NA mutations. HA mutants bound with a decreased efficiency to the cellular receptor and were cross-resistant to all the NA inhibitors tested. The NA mutation, an Arg-to-Lys mutation, was in a previously conserved site, Arg292, which forms part of a triarginyl cluster in the catalytic site. In enzyme assays, the NA was equally resistant to zanamivir and 4-amino-Neu5Ac2en but showed greater resistance to 6-carboxamide and was most resistant to a new carbocyclic NA inhibitor, GS4071, which also has a hydrophobic side chain at the 6 position. Consistent with enzyme assays, the lowest resistance in cell culture was seen to zanamivir, more resistance was seen to 6-carboxamide, and the greatest resistance was seen to GS4071. Substrate binding and enzyme activity were also decreased in the mutant, and consequently, virus replication in both plaque assays and liquid culture was compromised. Altered binding of the hydrophobic side chain at the 6 position or the triol group could account for the decreased binding of both the NA inhibitors and substrate.

* Corresponding author. Mailing address: Biomolecular Research Institute, 343 Royal Parade, Parkville, 3052 Australia. Phone: 61 3 9662 7200. Fax: 61 3 9662 7101. E-mail: jenny.mckimm-breschkin{at}bioresi.com.au.




This article has been cited by other articles:

  • Zurcher, T., Yates, P. J., Daly, J., Sahasrabudhe, A., Walters, M., Dash, L., Tisdale, M., McKimm-Breschkin, J. L. (2006). Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother 58: 723-732 [Abstract] [Full Text]  
  • Yen, H.-L., Hoffmann, E., Taylor, G., Scholtissek, C., Monto, A. S., Webster, R. G., Govorkova, E. A. (2006). Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.. J. Virol. 80: 8787-8795 [Abstract] [Full Text]  
  • Lu, B., Zhou, H., Ye, D., Kemble, G., Jin, H. (2005). Improvement of Influenza A/Fujian/411/02 (H3N2) Virus Growth in Embryonated Chicken Eggs by Balancing the Hemagglutinin and Neuraminidase Activities, Using Reverse Genetics. J. Virol. 79: 6763-6771 [Abstract] [Full Text]  
  • Jackson, D., Barclay, W., Zurcher, T. (2005). Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations. J Antimicrob Chemother 55: 162-169 [Abstract] [Full Text]  
  • McKimm-Breschkin, J., Trivedi, T., Hampson, A., Hay, A., Klimov, A., Tashiro, M., Hayden, F., Zambon, M. (2003). Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir. Antimicrob. Agents Chemother. 47: 2264-2272 [Abstract] [Full Text]  
  • Wang, M. Z., Tai, C. Y., Mendel, D. B. (2002). Mechanism by Which Mutations at His274 Alter Sensitivity of Influenza A Virus N1 Neuraminidase to Oseltamivir Carboxylate and Zanamivir. Antimicrob. Agents Chemother. 46: 3809-3816 [Abstract] [Full Text]  
  • Molla, A., Kati, W., Carrick, R., Steffy, K., Shi, Y., Montgomery, D., Gusick, N., Stoll, V. S., Stewart, K. D., Ng, T. I., Maring, C., Kempf, D. J., Kohlbrenner, W. (2002). In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675. J. Virol. 76: 5380-5386 [Abstract] [Full Text]  
  • Gubareva, L. V., Webster, R. G., Hayden, F. G. (2001). Comparison of the Activities of Zanamivir, Oseltamivir, and RWJ-270201 against Clinical Isolates of Influenza Virus and Neuraminidase Inhibitor-Resistant Variants. Antimicrob. Agents Chemother. 45: 3403-3408 [Abstract] [Full Text]  
  • Porotto, M., Greengard, O., Poltoratskaia, N., Horga, M.-A., Moscona, A. (2001). Human Parainfluenza Virus Type 3 HN-Receptor Interaction: Effect of 4-Guanidino-Neu5Ac2en on a Neuraminidase-Deficient Variant. J. Virol. 75: 7481-7488 [Abstract] [Full Text]  
  • Murrell, M. T., Porotto, M., Greengard, O., Poltoratskaia, N., Moscona, A. (2001). A Single Amino Acid Alteration in the Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Glycoprotein Confers Resistance to the Inhibitory Effects of Zanamivir on Receptor Binding and Neuraminidase Activity. J. Virol. 75: 6310-6320 [Abstract] [Full Text]  
  • Stephenson, I., Nicholson, K.G. (2001). Influenza: vaccination and treatment. Eur Respir J 17: 1282-1293 [Abstract] [Full Text]  
  • Couch, R. B. (2000). Prevention and Treatment of Influenza. NEJM 343: 1778-1787 [Full Text]  
  • Greengard, O., Poltoratskaia, N., Leikina, E., Zimmerberg, J., Moscona, A. (2000). The Anti-Influenza Virus Agent 4-GU-DANA (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA. J. Virol. 74: 11108-11114 [Abstract] [Full Text]  
  • Mitnaul, L. J., Matrosovich, M. N., Castrucci, M. R., Tuzikov, A. B., Bovin, N. V., Kobasa, D., Kawaoka, Y. (2000). Balanced Hemagglutinin and Neuraminidase Activities Are Critical for Efficient Replication of Influenza A Virus. J. Virol. 74: 6015-6020 [Abstract] [Full Text]  
  • Hughes, M. T., Matrosovich, M., Rodgers, M. E., McGregor, M., Kawaoka, Y. (2000). Influenza A Viruses Lacking Sialidase Activity Can Undergo Multiple Cycles of Replication in Cell Culture, Eggs, or Mice. J. Virol. 74: 5206-5212 [Abstract] [Full Text]  
  • Barnett, J. M., Cadman, A., Gor, D., Dempsey, M., Walters, M., Candlin, A., Tisdale, M., Morley, P. J., Owens, I. J., Fenton, R. J., Lewis, A. P., Claas, E. C. J., Rimmelzwaan, G. F., De Groot, R., Osterhaus, A. D. M. E. (2000). Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy Studies. Antimicrob. Agents Chemother. 44: 78-87 [Abstract] [Full Text]  
  • Rowley, K. V., Harvey, R., Barclay, W. S. (1999). Isolation and characterization of a transfectant influenza B virus altered in RNA segment 6. J. Gen. Virol. 80: 2353-2359 [Abstract] [Full Text]  
  • Tai, C. Y., Escarpe, P. A., Sidwell, R. W., Williams, M. A., Lew, W., Wu, H., Kim, C. U., Mendel, D. B. (1998). Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071. Antimicrob. Agents Chemother. 42: 3234-3241 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»